Found: 5
Select item for more details and to access through your institution.
Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 3, p. 507, doi. 10.1007/s10549-017-4203-y
- By:
- Publication type:
- Article
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 1, p. 88, doi. 10.1080/0284186X.2016.1234068
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 579, doi. 10.1007/s00280-007-0509-5
- By:
- Publication type:
- Article
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study.
- Published in:
- British Journal of Cancer, 2012, v. 107, n. 4, p. 639, doi. 10.1038/bjc.2012.328
- By:
- Publication type:
- Article
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study.
- Published in:
- 2011
- By:
- Publication type:
- journal article